List view / Grid view
12 May 2015 | By Victoria White
GBI Research reports on the highly diverse and innovative pipeline for Duchenne Muscular Dystrophy and Becker Muscular Dystrophy treatment...
8 May 2015 | By Victoria White
The Asia-Pacific treatment market for psoriasis will almost double in value, from $690 million in 2014 to $1.2 billion by 2021, representing a CAGR of 8.4%...
7 April 2015 | By Victoria White
Liver cancer treatment has the potential to undergo a major transformation over the next 10 years according to business intelligence provider GBI Research...
1 April 2015 | By Victoria White
The US treatment market for Rheumatoid Arthritis is set to increase in value from $6.4 billion in 2013 to $9.3 billion by 2020, says GBI Research...
27 March 2015 | By Victoria White
While antibiotics boast a vast pipeline, the majority is dominated by generics, as weak financial incentives and high fail rates have discouraged innovation..
18 March 2015 | By Victoria White
GBI Research reports that the US asthma treatment market value will increase from $11.7 billion in 2013 to an estimated $14 billion...
10 March 2015 | By GBI Research
Patent applications for novel pain therapeutics declined steadily in number from 4,970 in 2008 to 3,492 in 2012, an average annual decrease of 8%, as limited understanding of pain pathophysiology continues to hinder drug development in this arena, says business intelligence provider GBI Research...
30 January 2015 | By GBI Research
The Asia-Pacific therapeutics market for Ovarian Cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth Rate of 5.1%, says business intelligence provider GBI Research...
